期刊文献+

代谢组学在体外循环心脏手术器官损伤中的研究进展

Research progress of metabolomics in organ damage during cardiac surgery with cardiopulmonary bypass
下载PDF
导出
摘要 体外循环(CPB)主要应用于心脏手术,CPB会造成脑、心、肾等重要脏器的损害,产生相关的并发症。代谢组学是研究生物体受外部刺激所产生的全部变化的代谢产物的科学,CPB后机体的代谢物成分会发生变化。研究心脏手术围术期的代谢变化,可以为疾病的发病机制提供重要的见解,并有潜力识别新的生物标志物。本综述主要介绍代谢组学的现状,以及其在CPB心脏手术对脑、心、肾、肺等重要脏器损伤中的研究进展,并就代谢组学在该领域的未来做一展望。 Cardiopulmonary bypass(CPB)is mainly used in cardiac surgery.CPB can cause damage to the brain,heart,kidney and other important organs,and develop associated complications.Metabonomics is the science of studying the metabolites of all the changes in a biological system resulting from external stimuli,and the metabolite composition of the body will change after CPB.Studying metabolic changes in the perioperative period of cardiac surgery can provide important insights into the pathogenesis of the disease and potentially identify new biomarkers.This review mainly introduces the current status of metabolomics as well as its research progress in the brain damage,heart,kidney,lung and other important organs in CPB cardiac surgery,and looks into the future of metabolomics in this field.
作者 雷登 郑宝石 周军庆 LEI deng;ZHENG Baoshi;ZHOU Junqing(Department of Cardiothoracic Surgery,Shaoxing People’s Hospital,Shaoxing 312000,China;Department of Cardiothoracic Surgery,the First Affiliated Hospital of Guangxi Medical University,Nanning 530021,China)
出处 《广西医科大学学报》 CAS 2024年第1期150-155,共6页 Journal of Guangxi Medical University
基金 浙江大学绍兴医院青年基金(No.2022YB08) 广西重点研发计划项目(No.AB18126057)。
关键词 体外循环 代谢组学 先天性心脏病 脑损伤 急性肾损伤 低心排血量综合征 cardiopulmonary bypass metabolomics congenital heart disease brain damage acute kidney injury low cardiac output syndrome
  • 相关文献

二级参考文献33

  • 1Di Eusanio M, Schepens M, Morshuis W, Dossche K, Pacini D, Di Marco L, et al. Operations on the thoracic aorta and ante grade selective cerebral perfusion: Our experience with 462 patients. Ital Heart J 2004;5:217-22.
  • 2Di Eusanio M, Schepens MA, Morshuis WJ, Di Bartolomeo R, Pierangeli A, Dossche KM. Antegrade selective cerebral perfusion during operations on the thoracic aorta: Factors influencing survival and neurologic outcome in 413 patients. J Thorac Cardiovasc Surg 2002; 124: 1080-6. doi: 10.1 067/mtc.2002.124994.
  • 3Di Eusanio M, Schepens MA, Morshuis WJ, Dossche KM, Di Bartolomeo R, Pacini D, et at. Brain protection using antegrade selective cerebral perfusion: A multicenter study. Ann Thorac Surg 2003;76:1181-8. doi: 10.1016/S0003-4975(03)00824-5.
  • 4Kazui T, Yamashita K, Washiyama N, Terada H, Bashar AH, Suzuki T, et at. Usefulness of ante grade selective cerebral perfusion during aortic arch operations. Ann Thorac Surg 2002;74:S1806-9. doi: 0.1 016/S0003-4975(02)04150-4.
  • 5Liang MY, Tang ZX, Chen GX, Rong J, Yao JP, Chen Z, et al. Is selective antegrade cerebral perfusion superior to retrograde cerebral perfusion for brain protection during deep hypothermic circulatory arrest? Metabolic evidence from microdialysis. Crit Care Med 20 14;42:e319-28. doi: 10.1 097/ccm.0000000000000220.
  • 6Zou L, Liu J, Zhang H, Wu S, Long C, Ji B, et at. A rabbit model of antegrade selective cerebral perfusion with cardioplegic arrest. Perfusion 2015. pii: 0267659115599835. doi: 10.1177/0267659115599835.
  • 7Pan X, Sun L, Ma W, Tang Y, Long C, Tian L, et al. Overactivation of poly (adenosine phosphate-ribose) polymerase I and molecular events in neuronal injury after deep hypothermic circulatory arrest: Study in a rabbit model. J Thorac Cardiovasc Surg 2007;134: 1227-33. doi: 1O.1016/j.jtcvs.2007.05.062.
  • 8Wang Q, Yang J, Long C, Zhao J, Li Y, Xue Q, et at. Hyperoxia management during deep hypothermia for cerebral protection in circulatory arrest rabbit model. ASAIO J 2012;58:330-6. doi: 10.1097 IMAT.ObO 13e318251 dfab.
  • 9Hu ZP, Browne ER, Liu T, Angel TE, Ho PC, Chan EC. Metabonomic profiling ofTASTPM transgenic Alzheimer's disease mouse model. J Proteome Res 2012;11:5903-13. doi: 10.10211pr300666p.
  • 10Nesnow S, Padgett WT, Moore T. Propiconazole induces alterations in the hepatic metabolome of mice: Relevance to propiconazole-induced hepatocarcinogenesis. Toxicol Sci 2011;120:297-309. doi: 10.10931 toxsci/kfrOl2.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部